You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Reactivity
Conjugation
Biologically Active
Featured Product
Search results for: 'recombinant'
Unconjugated
Predicted: 68.2 KDa. Observed: 60-90 KDa, reducing conditions
Mouse
Ala31-Ser418
C-mFc
50 μg, 500 μg, 1 mg, 10 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 16.3 KDa. Observed: 20-30 KDa, reducing conditions
Human
Gln51-Leu183
N-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 38.1 KDa. Observed: 50-90 KDa, reducing conditions
Mouse
Leu20-Lys338
C-6His
50 μg, 500 μg, 1 mg, 10 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 76.2 KDa. Observed: 85 KDa, reducing conditions
Human
Val20-Pro698
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 85.6 KDa. Observed: 85-90 KDa, reducing conditions
Human
Asn22-Gln779
C-6His
10 μg, 500 μg, 1 mg, 50 μgUnconjugated
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 44 KDa. Observed: 55-75 KDa, reducing conditions
Human
Leu24-Gln186
C-Fc-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.7 KDa. Observed: 18 KDa, reducing conditions
Mouse
Gln23-Ala173
N-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 13.1 KDa. Observed: 22 KDa, reducing conditions
Human
Lys12-Cys118
C-6His
10 μg, 500 μg, 1 mg, 50 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 47.3 KDa. Observed: 52-58 KDa, reducing conditions
Human
Met1-Thr406
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 43.4 KDa. Observed: 35-40 KDa, reducing conditions
Human
Met1-Pro376
C-6His
500 μg, 1 mg, 10 μg, 50 μg